The Effects of Food on Cannabidiol Bioaccessibility

被引:26
作者
Mozaffari, Khadijeh [1 ]
Willette, Stephanie [2 ]
Lucker, Ben F. [2 ]
Kovar, Sarah E. [2 ]
Holguin, Francisco Omar [1 ]
Guzman, Ivette [1 ]
机构
[1] New Mexico State Univ, Dept Plant & Environm Sci, Las Cruces, NM 88003 USA
[2] Trait Biosci, Los Alamos, NM 87544 USA
关键词
CBD; hemp; cannabis; in vitro digestion; fasted digestion; fed digestion; UPLC-MS; metabolites; BILE-SALT; BIOAVAILABILITY; PHARMACOKINETICS; CANNABINOIDS; ABSORPTION; FLAVONOIDS; DIGESTION; EFFICACY; SATIVA; ENZYME;
D O I
10.3390/molecules26123573
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cannabidiol (CBD) is a hydrophobic non-psychoactive compound with therapeutic characteristics. Animal and human studies have shown its poor oral bioavailability in vivo, and the impact of consuming lipid-soluble CBD with and without food on gut bioaccessibility has not been explored. The purpose of this research was to study the bioaccessibility of CBD after a three-phase upper digestion experiment with and without food, and to test lipase activity with different substrate concentrations. Our results showed that lipase enzyme activity and fatty acid absorption increased in the presence of bile salts, which may also contribute to an increase in CBD bioaccessibility. The food matrix used was a mixture of olive oil and baby food. Overall, the fed-state digestion revealed significantly higher micellarization efficiency for CBD (14.15 +/- 0.6% for 10 mg and 22.67 +/- 2.1% for 100 mg CBD ingested) than the fasted state digestion of CBD (0.65 +/- 0.7% for 10 mg and 0.14 +/- 0.1% for 100 mg CBD ingested). The increase in bioaccessibility of CBD with food could be explained by the fact that micelle formation from hydrolyzed lipids aid in bioaccessibility of hydrophobic molecules. In conclusion, the bioaccessibility of CBD depends on the food matrix and the presence of lipase and bile salts.
引用
收藏
页数:11
相关论文
共 46 条
[1]   Neuroprotective Effects of the Nonpsychoactive Cannabinoid Cannabidiol in Hypoxic-Ischemic Newborn Piglets [J].
Alvarez, Francisco J. ;
Lafuente, Hector ;
Rey-Santano, M. Carmen ;
Mielgo, Victoria E. ;
Gastiasoro, Elena ;
Rueda, Miguel ;
Pertwee, Roger G. ;
Castillo, Ana I. ;
Romero, Julian ;
Martinez-Orgado, Jose .
PEDIATRIC RESEARCH, 2008, 64 (06) :653-658
[2]   Cannabinoids: Occurrence and Medicinal Chemistry [J].
Appendino, G. ;
Chianese, G. ;
Taglialatela-Scafati, O. .
CURRENT MEDICINAL CHEMISTRY, 2011, 18 (07) :1085-1099
[3]   The Potential of Cannabidiol as a Treatment for Psychosis and Addiction: Who Benefits Most? A Systematic Review [J].
Batalla, Albert ;
Janssen, Hella ;
Gangadin, Shirai S. ;
Bossong, Matthijs G. .
JOURNAL OF CLINICAL MEDICINE, 2019, 8 (07)
[4]   A new ESI-LC/MS approach for comprehensive metabolic profiling of phytocannabinoids in Cannabis [J].
Berman, Paula ;
Futoran, Kate ;
Lewitus, Gil M. ;
Mukha, Dzmitry ;
Benami, Maya ;
Shlomi, Tomer ;
Meiri, David .
SCIENTIFIC REPORTS, 2018, 8
[5]   Nature and consequences of non-covalent interactions between flavonoids and macronutrients in foods [J].
Bordenave, Nicolas ;
Hamaker, Bruce R. ;
Ferruzzi, Mario G. .
FOOD & FUNCTION, 2014, 5 (01) :18-34
[6]   Cannabidiol, neuroprotection and neuropsychiatric disorders [J].
Campos, Alline C. ;
Fogaca, Manoela V. ;
Sonego, Andreza B. ;
Guimaraes, Francisco S. .
PHARMACOLOGICAL RESEARCH, 2016, 112 :119-127
[7]   The effect of Pro NanoLipospheres (PNL) formulation containing natural absorption enhancers on the oral bioavailability of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in a rat model [J].
Cherniakov, Irina ;
Izgelov, Dvora ;
Domb, Abraham J. ;
Hoffman, Amnon .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 109 :21-30
[8]   The solute carrier family 10 (SLC10): Beyond bile acid transport [J].
da Silva, Tatiana Claro ;
Polli, James E. ;
Swaan, Peter W. .
MOLECULAR ASPECTS OF MEDICINE, 2013, 34 (2-3) :252-269
[9]   Transport and metabolism of flavonoids from Chinese herbal remedy Xiaochaihu-tang across human intestinal Caco-2 cell monolayers [J].
Dai, Jie-Yu ;
Yang, Jun-ling ;
Li, Chuan .
ACTA PHARMACOLOGICA SINICA, 2008, 29 (09) :1086-1093
[10]   Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ9-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behaviour [J].
Deiana, Serena ;
Watanabe, Akihito ;
Yamasaki, Yuki ;
Amada, Naoki ;
Arthur, Marlene ;
Fleming, Shona ;
Woodcock, Hilary ;
Dorward, Patricia ;
Pigliacampo, Barbara ;
Close, Steve ;
Platt, Bettina ;
Riedel, Gernot .
PSYCHOPHARMACOLOGY, 2012, 219 (03) :859-873